Teligent Total Current Liabilities 2010-2021 | TLGT
Teligent total current liabilities from 2010 to 2021. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Teligent Annual Total Current Liabilities
(Millions of US $) |
| 2020 |
$23 |
| 2019 |
$17 |
| 2018 |
$33 |
| 2017 |
$19 |
| 2016 |
$15 |
| 2015 |
$11 |
| 2014 |
$13 |
| 2013 |
$5 |
| 2012 |
$2 |
| 2011 |
$1 |
| 2010 |
$1 |
| 2009 |
$1 |
Teligent Quarterly Total Current Liabilities
(Millions of US $) |
| 2021-06-30 |
$13 |
| 2021-03-31 |
$14 |
| 2020-12-31 |
$23 |
| 2020-09-30 |
$22 |
| 2020-06-30 |
$24 |
| 2020-03-31 |
$18 |
| 2019-12-31 |
$17 |
| 2019-09-30 |
$35 |
| 2019-06-30 |
$30 |
| 2019-03-31 |
$31 |
| 2018-12-31 |
$33 |
| 2018-09-30 |
$39 |
| 2018-06-30 |
$18 |
| 2018-03-31 |
$17 |
| 2017-12-31 |
$19 |
| 2017-09-30 |
$25 |
| 2017-06-30 |
$22 |
| 2017-03-31 |
$18 |
| 2016-12-31 |
$15 |
| 2016-09-30 |
$13 |
| 2016-06-30 |
$13 |
| 2016-03-31 |
$13 |
| 2015-12-31 |
$11 |
| 2015-09-30 |
$9 |
| 2015-06-30 |
$13 |
| 2015-03-31 |
$15 |
| 2014-12-31 |
$13 |
| 2014-09-30 |
$12 |
| 2014-06-30 |
$5 |
| 2014-03-31 |
$4 |
| 2013-12-31 |
$5 |
| 2013-09-30 |
$3 |
| 2013-06-30 |
$3 |
| 2013-03-31 |
$2 |
| 2012-12-31 |
$2 |
| 2012-09-30 |
$1 |
| 2012-06-30 |
$1 |
| 2012-03-31 |
$2 |
| 2011-12-31 |
$1 |
| 2011-09-30 |
$1 |
| 2011-06-30 |
$1 |
| 2011-03-31 |
$1 |
| 2010-12-31 |
$1 |
| 2010-09-30 |
$1 |
| 2010-06-30 |
$1 |
| 2010-03-31 |
$1 |
| 2009-12-31 |
$1 |
| 2009-09-30 |
$1 |
| 2009-06-30 |
$1 |
| 2009-03-31 |
$6 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.000B |
$0.000B |
|
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
|
